5 assets in Vascular Occlusion Disorder

Therapeutic assets addressing Vascular Occlusion Disorder, rated under Floatz methodology v0.2 and sorted by current rating.

Asset	Sponsor	Phase	Rating
Atorvastatin Vascular Occlusion Disorder	Zhongda Hospital	P4	BB (65)
Clevidipine Vascular Occlusion Disorder	ProMedica Health System	P3	BB (64)
Compound Edaravone Vascular Occlusion Disorder	Beijing Tiantan Hospital	P3	BB (64)
Tirofiban Vascular Occlusion Disorder	Xiang Luo	P2/3	B (61)
Minocycline Vascular Occlusion Disorder	Xiang Luo	P2/3	B (57)